BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12090594)

  • 1. Sclerosing stromal tumors, thecomas, and fibromas of the ovary: an immunohistochemical profile.
    Tiltman AJ; Haffajee Z
    Int J Gynecol Pathol; 1999 Jul; 18(3):254-8. PubMed ID: 12090594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Benign unclassified tumor of the gonadal stroma: importance of alpha-inhibin expression].
    Sironi M; Santangelo M; Pasquinelli G; Spinelli M
    Pathologica; 2001 Feb; 93(1):50-6. PubMed ID: 11294020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic and immunohistochemical evidence for considering ovarian myxoma as a variant of the thecoma-fibroma group of ovarian stromal tumors.
    Costa MJ; Morris R; DeRose PB; Cohen C
    Arch Pathol Lab Med; 1993 Aug; 117(8):802-8. PubMed ID: 7688213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases.
    Movahedi-Lankarani S; Kurman RJ
    Am J Surg Pathol; 2002 Nov; 26(11):1477-83. PubMed ID: 12409724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogenetic consideration of ovarian sex cord-stromal tumors analyzed by expression pattern of cytokeratins, vimentin, and laminin. Correlation studies with human gonads.
    Park SH; Kim I
    Pathol Res Pract; 1994 May; 190(5):449-56. PubMed ID: 7527534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of inhibin in the identification of granulosa cell tumors of the ovary.
    Hildebrandt RH; Rouse RV; Longacre TA
    Hum Pathol; 1997 Dec; 28(12):1387-95. PubMed ID: 9416696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ovarian tumors with endocrine function].
    Guo LN; Liu TH; Sun AJ; Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):217-20. PubMed ID: 15256111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cellular fibroma of the ovary: description of a case].
    Zanelli M; Cortecchia S; Folicaldi S; Pasquinelli G; Bondi A
    Pathologica; 2002 Aug; 94(4):196-200. PubMed ID: 12325418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological Characteristics of Ovarian Sclerosing Stromal Tumor with an Emphasis on TFE3 Overexpression.
    Park CK; Kim HS
    Anticancer Res; 2017 Oct; 37(10):5441-5447. PubMed ID: 28982854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TFE3 nuclear expression as a novel biomarker of ovarian sclerosing stromal tumors and associated with its histological morphology.
    Zhao L; Yang Z; Zhou Y; Liu Y; Luo Q; Jiang Q; Wang H; Wang N
    J Ovarian Res; 2023 Aug; 16(1):152. PubMed ID: 37528481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smooth muscle differentiation in normal human ovaries, ovarian stromal hyperplasia and ovarian granulosa-stromal cells tumors.
    Santini D; Ceccarelli C; Leone O; Pasquinelli G; Piana S; Marabini A; Martinelli GN
    Mod Pathol; 1995 Jan; 8(1):25-30. PubMed ID: 7731938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerosing stromal tumour--a rare ovarian benign neoplasm: description of three cases.
    Korobowicz E; Wronecki L; Siezieniewska-SkowroĊ„ska Z
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():131-2. PubMed ID: 11820573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors.
    Cao QJ; Jones JG; Li M
    Int J Gynecol Pathol; 2001 Oct; 20(4):346-52. PubMed ID: 11603218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibin immunohistochemical staining: a practical approach for the surgical pathologist in the diagnoses of ovarian sex cord-stromal tumors.
    Zheng W; Senturk BZ; Parkash V
    Adv Anat Pathol; 2003 Jan; 10(1):27-38. PubMed ID: 12502966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
    Cathro HP; Stoler MH
    Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic utility of inhibin staining in ovarian neoplasms.
    Pelkey TJ; Frierson HF; Mills SE; Stoler MH
    Int J Gynecol Pathol; 1998 Apr; 17(2):97-105. PubMed ID: 9553804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerosis in Sex Cord-Stromal Tumors Other Than the Sclerosing Stromal Tumor: A Report of 70 Cases.
    Devins KM; Young RH
    Am J Surg Pathol; 2023 Jul; 47(7):774-784. PubMed ID: 37184091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine retiform sertoli-leydig cell tumor: report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors.
    Czernobilsky B; Mamet Y; David MB; Atlas I; Gitstein G; Lifschitz-Mercer B
    Int J Gynecol Pathol; 2005 Oct; 24(4):335-40. PubMed ID: 16175078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerosing stromal tumor of the ovary: an ultrastructural and immunohistochemical analysis with histogenetic considerations.
    Shaw JA; Dabbs DJ; Geisinger KR
    Ultrastruct Pathol; 1992; 16(3):363-77. PubMed ID: 1316660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
    Oliva E; Garcia-Miralles N; Vu Q; Young RH
    Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.